Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BioShuttle-mediated plasmid transfer.

Klaus Braun1, Leonie von Brasch, Ruediger Pipkorn

  • 1Division of Molecular Toxicology, German Cancer Research Center, INF 280, D-69120 Heidelberg, Germany. k.braun@dkfz.de

International Journal of Medical Sciences
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.

NPJ precision oncology·2026
Same author

Helical Tomotherapy in Local Advanced Breast Cancer Following Mastectomy: Long-term Results and Late Toxicity Analysis.

In vivo (Athens, Greece)·2026
Same author

Improved Progression-Free Survival Following Dose-Escalated Versus Standard-Dose Postoperative Radiation Therapy for High-Risk Meningiomas: An International Multicenter Individual Patient-Level Meta-Analysis (FIRESTORM).

International journal of radiation oncology, biology, physics·2026
Same author

Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.

Science translational medicine·2026
Same author

Predicting Difficult Tracheal Intubation in Head and Neck Cancer Patients with Osteoradionecrosis: Development of the ORN-Difficult-Airway-Score.

Medical sciences (Basel, Switzerland)·2026
Same author

3D range modulators for fast, conformal carbon ion therapy: anthropomorphic phantom validation and robustness analysis.

Physics in medicine and biology·2026

This study introduces BioShuttle, a novel non-viral gene delivery system. BioShuttle efficiently transports plasmids into cell nuclei, offering a promising tool for genetic disease treatments.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Effective gene transfer is crucial for treating genetic diseases, including cancer.
  • Current non-viral methods often lack efficiency and specificity in delivering genetic material to target cells.

Purpose of the Study:

  • To develop and evaluate a novel peptide-based non-viral gene transfer system, termed BioShuttle.
  • To demonstrate the system's capability for efficient plasmid DNA delivery into cell nuclei.

Main Methods:

  • Development of a BioShuttle system incorporating a nuclear localization sequence for targeted delivery.
  • Transfection of HeLa cells with a plasmid (phNIS-IRES-EGFP) encoding two reporter genes.
  • Quantification of gene transfer efficiency via sodium iodide symporter activity measurements and EGFP expression analysis using Confocal Laser Scanning Microscopy (CLSM).
Keywords:
Quantification of gene transfergene targetingnon-viral vectorsnucleus-addressed delivery

Related Experiment Videos

Main Results:

  • The BioShuttle system successfully delivered the plasmid DNA into the nuclei of HeLa cells.
  • Gene transfer efficiency was effectively quantified using both reporter gene activity and advanced imaging techniques.
  • Biostatistical analysis of CLSM images confirmed successful gene expression.

Conclusions:

  • The developed BioShuttle technology represents an effective non-viral tool for gene transfer.
  • This system shows potential for applications in genetic therapies requiring precise delivery of genetic material.